跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Invega Hafyera - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Invega Hafyera
Approved
STANDARD
Invega Hafyera
Janssen Pharmaceutica NV
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e5d4f48b13c7d6f4
Company
Janssen Pharmaceutica NV
Type
Standard
Approval Details
Approval Id
e5d4f48b13c7d6f4
Drug Approval Philippines Name
Invega Hafyera
Product Name
Invega Hafyera
Registration Number
DR-XY49222
Brand Name
Invega Hafyera
Generic Name
Paliperidone (as palmitate)
Dosage Form
Prolonged-Release Suspension for Injection (Gluteal I.M.)
Dosage Strength
200 mg/mL (1 g/5 mL)
Manufacturer
Janssen Pharmaceutica NV
Importer
Johnson & Johnson (Philippines). Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/janssen-pharmaceutica-nv
Issuance Date
23 September 2024
Expiry Date
23 September 2029
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e5d4f48b13c7d6f4
Type
Standard
Back to Philippines FDA Approvals